α 2A-adrenoceptors regulate sympathetic transmitter release in mice kidneys

British Journal of Pharmacology

Volumn 150, Issue 1, 2007, Pages 121-127

  Vonend, O ^a   Habbel, S ^a   Stegbauer, J ^a   Roth, J ^b   Hein, L ^c   Rump, L C ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

2A adrenoceptor; ATP; Noradrenaline; P2 receptor; Receptor deficient mouse; Sympathetic neurotransmission

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALPHA 2A ADRENERGIC RECEPTOR; NORADRENALIN; PHENTOLAMINE; PLATINUM; PRAZOSIN; PURINE P2 RECEPTOR; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; RAUWOLSCINE;

ADRENERGIC TRANSMISSION; ALPHA ADRENERGIC RECEPTOR BLOCKING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTRODE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KIDNEY; KIDNEY NERVE; KNOCKOUT MOUSE; MALE; MOUSE; NEUROTRANSMITTER RELEASE; NONHUMAN; NORADRENALIN RELEASE; PERFUSION PRESSURE; PRESSOR RESPONSE; PRESYNAPTIC INHIBITION; PRIORITY JOURNAL; WILD TYPE;

ADENOSINE TRIPHOSPHATE; ADRENERGIC ALPHA-AGONISTS; ANIMALS; ELECTRIC STIMULATION; KIDNEY; MALE; MICE; MICE, INBRED C57BL; RECEPTORS, ADRENERGIC, ALPHA-2;

EID: 33846217456     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706961     Document Type: Article

References (28)

1. Amann K, Koch A, Hofstetter J, Gross ML, Haas C, Orth SR et al. (2001). Glomerulosclerosis and progression: effect of subanti-hypertensive doses of alpha and beta blockers. Kidney Int 60: 1309-1323.
2. Bohmann C, von Kugelgen I, Rump LC (1997). P2-receptor modulation of noradrenergic neurotransmission in rat kidney. Br J Pharmacol 121: 1255-1262.
3. Brede M, Wiesmann F, Jahns R, Hadamek K, Arnolt C, Neubauer S et al. (2002). Feedback inhibition of catecholamine release by two different alpha2-adrenoceptor subtypes prevents progression of heart failure. Circulation 106: 2491-2496.
4. Bultmann R, von Kugelgen I, Starke K (1991). Contraction-mediating alpha 2-adrenoceptors in the mouse vas deferens. Naunyn Schmiedebergs Arch Pharmacol 343: 623-632.
5. Campese VM (1997). Neurogenic factors and hypertension in chronic renal failure. J Nephrol 10: 184-187.
6. Campese VM, Krol E (2002). Neurogenic factors in renal hypertension. Curr Hypertens Rep 4: 256-260.
7. Cleary L, Vandeputte C, Docherty JR (2003). Investigation of postjunctional alpha1- and alpha2-adrenoceptor subtypes in vas deferens from wild-type and alpha(2A/D)-adrenoceptor knockout mice. Br J Pharmacol 138: 1069-1076.
8. Garrett BN, Kaplan NM (1980). Clonidine in the treatment of hypertension. J Cardiovasc Pharmacol 2 (Suppl 1): S61-S71.
9. Hein L, Altman JD, Kobilka BK (1999). Two functionally distinct alpha2-adrenergic receptors regulate sympathetic neurotransmission. Nature 402: 181-184.
10. Inscho EW (2001). Renal microvascular effects of P2 receptor stimulation. Clin Exp Pharmacol Physiol 28: 332-339.
11. Koomans HA, Blankestijn PJ, Joles JA (2004). Sympathetic hyperactivity in chronic renal failure: a wake-up call. J Am Soc Nephrol 15: 524-537.
12. Lambrecht G (2000). Agonists and antagonists acting at P2X receptors: selectivity profiles and functional implications. Naunyn Schmiedebergs Arch Pharmacol 362: 340-350.
13. Lorenz W, Lomasney JW, Collins S, Regan JW, Caron MG, Lefkowitz RJ (1990). Expression of three alpha 2-adrenergic receptor subtypes in rat tissues: implications for alpha 2 receptor classification. Mol Pharmacol 38: 599-603.
14. Queiroz G, Talaia C, Goncalves J (2003). ATP modulates noradrenaline release by activation of inhibitory P2Y receptors and facilitatory P2X receptors in the rat vas deferens. J Pharmacol Exp Ther 307: 809-815.
15. Ritz E, Amann K, Fliser D (1998). The sympathetic nervous system and the kidney: its importance in renal diseases. Blood Press Suppl 3: 14-19.
16. Rump LC, Amann K, Orth S, Ritz E (2000). Sympathetic overactivity in renal disease: a window to understand progression and cardiovascular complications of uraemia? Nephrol Dial Transplant 15: 1735-1738.
17. Schohn D, Weidmann P, Jahn H, Beretta-Piccoli C (1985). Norepinephrine-related mechanism in hypertension accompanying renal failure. Kidney Int 28: 814-822.
18. Schwartz DD, Malik KU (1989). Renal periarterial nerve stimulation-induced vasoconstriction at low frequencies is primarily due to release of a purinergic transmitter in the rat. J Pharmacol Exp Ther 250: 764-771.
19. Sesti C, Koyama M, Broekman MJ, Marcus AJ, Levi R (2003). Ectonucleotidase in sympathetic nerve endings modulates ATP and norepinephrine exocytosis in myocardial ischemia. J Pharmacol Exp Ther 306: 238-244.
20. Stegbauer J, Vonend O, Habbel S, Quack I, Sellin L, Gross V et al. (2005). Angiotensin II modulates renal sympathetic neurotransmission through nitric oxide in AT2 receptor knockout mice. J Hypertens 23: 1691-1698.
21. Trendelenburg AU, Klebroff W, Hein L, Starke K (2001). A study of presynaptic alpha2-autoreceptors in alpha2A/D-, alpha2B- and alpha2C-adrenoceptor-deficient mice. Naunyn Schmiedebergs Arch Pharmacol 364: 117-130.
22. Trendelenburg AU, Philipp M, Meyer A, Klebroff W, Hein L, Starke K (2003). All three alpha2-adrenoceptor types serve as autoreceptors in postganglionic sympathetic neurons. Naunyn Schmiedebergs Arch Pharmacol 368: 504-512.
23. Vonend O, Grote T, Oberhauser V, Von Kugelgen I, Rump LC (2003a). P2Y-receptors stimulating the proliferation of human mesangial cells through the MAPK42/44 pathway. Br J Pharmacol 139: 1119-1126.
24. Vonend O, Marsalek P, Russ H, Wulkow R, Oberhauser V, Rump LC (2003b). Moxonidine treatment of hypertensive patients with advanced renal failure. J Hypertens 21: 1709-1717.
25. Vonend O, Oberhauser V, von Kugelgen I, Apel TW, Amann K, Ritz E et al. (2002). ATP release in human kidney cortex and its mitogenic effects in visceral glomerular epithelial cells. Kidney Int 61: 1617-1626.
26. Vonend O, Okonek A, Stegbauer J, Habbel S, Quack I, Rump LC (2005a). Renovascular effects of sympathetic cotransmitters ATP and NPY are age-dependent in spontaneously hypertensive rats. Cardiovasc Res 66: 345-352.
27. Vonend O, Stegbauer J, Sojka J, Habbel S, Quack I, Robaye B et al. (2005b). Noradrenaline and extracellular nucleotide cotransmission involves activation of vasoconstrictive P2X(1,3)- and P2Y6-like receptors in mouse perfused kidney. Br J Pharmacol 145: 66-74.
28. von Kugelgen I, Norenberg W, Koch H, Meyer A, Illes P, Starke K (1999). P2-receptors controlling neurotransmitter release from postganglionic sympathetic neurones. Prog Brain Res 120: 173-182.